GE

231.8

+1.12%↑

RTX

135.35

-0.13%↓

CAT

353.49

+1.06%↑

BA

205.84

-0.2%↓

HON

222.76

+0.22%↑

GE

231.8

+1.12%↑

RTX

135.35

-0.13%↓

CAT

353.49

+1.06%↑

BA

205.84

-0.2%↓

HON

222.76

+0.22%↑

GE

231.8

+1.12%↑

RTX

135.35

-0.13%↓

CAT

353.49

+1.06%↑

BA

205.84

-0.2%↓

HON

222.76

+0.22%↑

GE

231.8

+1.12%↑

RTX

135.35

-0.13%↓

CAT

353.49

+1.06%↑

BA

205.84

-0.2%↓

HON

222.76

+0.22%↑

GE

231.8

+1.12%↑

RTX

135.35

-0.13%↓

CAT

353.49

+1.06%↑

BA

205.84

-0.2%↓

HON

222.76

+0.22%↑

Search

Enovis Corp

Închisă

SectorSectorul industrial

36.1 0.98

Rezumat

Modificarea prețului

24h

Curent

Minim

35.03

Maxim

36.14

Indicatori cheie

By Trading Economics

Venit

647M

-56M

Vânzări

-2.1M

559M

EPS

0.81

Marjă de profit

-9.968

Angajați

7,367

EBITDA

535M

-56M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+57.76% upside

Dividende

By Dow Jones

Următoarele câștiguri

6 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-372M

2.1B

Deschiderea anterioară

35.12

Închiderea anterioară

36.1

Enovis Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

7 ian. 2025, 23:28 UTC

Principalele dinamici ale pieței

Maplebear Up on S&P MidCap 400 Inclusion

Comparație

Modificare preț

Enovis Corp Așteptări

Obiectiv de preț

By TipRanks

57.76% sus

Prognoză pe 12 luni

Medie 57.14 USD  57.76%

Maxim 75 USD

Minim 37 USD

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruEnovis Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

8 ratings

7

Cumpărare

1

Păstrare

0

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Enovis Corp

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.